River & Mercantile Asset Management LLP grew its stake in shares of Mylan NV (NASDAQ:MYL) by 25.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 81,171 shares of the company’s stock after purchasing an additional 16,529 shares during the period. River & Mercantile Asset Management LLP’s holdings in Mylan were worth $2,971,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Bank of New York Mellon Corp boosted its stake in Mylan by 32.1% during the second quarter. Bank of New York Mellon Corp now owns 9,408,218 shares of the company’s stock worth $340,012,000 after acquiring an additional 2,284,545 shares in the last quarter. Bank of Montreal Can boosted its stake in Mylan by 605.0% during the third quarter. Bank of Montreal Can now owns 2,193,264 shares of the company’s stock worth $80,274,000 after acquiring an additional 1,882,157 shares in the last quarter. Orbimed Advisors LLC boosted its stake in Mylan by 77.7% during the second quarter. Orbimed Advisors LLC now owns 3,702,800 shares of the company’s stock worth $133,819,000 after acquiring an additional 1,618,500 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its stake in Mylan by 522.2% during the second quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,131,937 shares of the company’s stock worth $40,908,000 after acquiring an additional 950,000 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Mylan by 14.4% during the second quarter. Dimensional Fund Advisors LP now owns 5,132,430 shares of the company’s stock worth $185,499,000 after acquiring an additional 644,643 shares in the last quarter. 82.17% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Mylan stock opened at $30.55 on Friday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.26 and a quick ratio of 0.77. The stock has a market capitalization of $16.42 billion, a price-to-earnings ratio of 6.70, a PEG ratio of 1.05 and a beta of 1.49. Mylan NV has a 52-week low of $30.33 and a 52-week high of $47.82.
Mylan (NASDAQ:MYL) last released its quarterly earnings data on Monday, November 5th. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.06. Mylan had a net margin of 4.71% and a return on equity of 19.39%. The firm had revenue of $2.86 billion during the quarter, compared to analysts’ expectations of $2.91 billion. During the same period in the previous year, the company earned $1.10 earnings per share. The firm’s quarterly revenue was down 4.2% on a year-over-year basis. As a group, research analysts predict that Mylan NV will post 4.66 EPS for the current year.
Several research analysts have issued reports on the stock. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $41.00 target price on shares of Mylan in a report on Monday, November 5th. ValuEngine raised shares of Mylan from a “sell” rating to a “hold” rating in a report on Tuesday, August 14th. Royal Bank of Canada raised shares of Mylan from a “sector perform” rating to an “outperform” rating and set a $53.00 target price for the company in a report on Monday, August 13th. Morgan Stanley cut shares of Mylan from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $46.00 to $36.00 in a report on Tuesday, October 9th. Finally, Mizuho cut shares of Mylan from a “buy” rating to a “neutral” rating in a report on Friday, October 5th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. Mylan has an average rating of “Buy” and a consensus price target of $46.56.
TRADEMARK VIOLATION WARNING: This article was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.thelincolnianonline.com/2018/12/08/river-mercantile-asset-management-llp-increases-stake-in-mylan-nv-myl.html.
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.
Featured Story: How does a reverse stock split work?
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.